Logo image of CNR

CORE NATURAL RESOURCES INC (CNR) Stock Fundamental Analysis

NYSE:CNR - New York Stock Exchange, Inc. - US20854L1089 - Common Stock - Currency: USD

77.84  -3.95 (-4.83%)

After market: 77.84 0 (0%)

Fundamental Rating

6

Taking everything into account, CNR scores 6 out of 10 in our fundamental rating. CNR was compared to 211 industry peers in the Oil, Gas & Consumable Fuels industry. CNR is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. CNR scores decently on growth, while it is valued quite cheap. This could make an interesting combination. These ratings could make CNR a good candidate for value investing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

CNR had positive earnings in the past year.
CNR had a positive operating cash flow in the past year.
In multiple years CNR reported negative net income over the last 5 years.
CNR had a positive operating cash flow in 4 of the past 5 years.
CNR Yearly Net Income VS EBIT VS OCF VS FCFCNR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M

1.2 Ratios

Looking at the Return On Assets, with a value of 14.61%, CNR belongs to the top of the industry, outperforming 86.27% of the companies in the same industry.
CNR has a better Return On Equity (26.98%) than 84.31% of its industry peers.
CNR's Return On Invested Capital of 17.15% is amongst the best of the industry. CNR outperforms 87.25% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CNR is significantly below the industry average of 28.75%.
The 3 year average ROIC (21.68%) for CNR is well above the current ROIC(17.15%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 14.61%
ROE 26.98%
ROIC 17.15%
ROA(3y)14.37%
ROA(5y)9.11%
ROE(3y)31.32%
ROE(5y)21.93%
ROIC(3y)21.68%
ROIC(5y)14.45%
CNR Yearly ROA, ROE, ROICCNR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20 30 40

1.3 Margins

CNR has a Profit Margin of 18.23%. This is in the better half of the industry: CNR outperforms 64.22% of its industry peers.
In the last couple of years the Profit Margin of CNR has grown nicely.
Looking at the Operating Margin, with a value of 20.80%, CNR is in line with its industry, outperforming 48.04% of the companies in the same industry.
In the last couple of years the Operating Margin of CNR has grown nicely.
CNR's Gross Margin of 35.16% is in line compared to the rest of the industry. CNR outperforms 43.14% of its industry peers.
In the last couple of years the Gross Margin of CNR has declined.
Industry RankSector Rank
OM 20.8%
PM (TTM) 18.23%
GM 35.16%
OM growth 3Y181.05%
OM growth 5Y11.64%
PM growth 3YN/A
PM growth 5Y20.82%
GM growth 3Y-22.64%
GM growth 5Y-14.47%
CNR Yearly Profit, Operating, Gross MarginsCNR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60 80

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CNR is creating value.
There is no outstanding debt for CNR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CNR Yearly Shares OutstandingCNR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
CNR Yearly Total Debt VS Total AssetsCNR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B 2.5B

2.2 Solvency

CNR has an Altman-Z score of 4.06. This indicates that CNR is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of CNR (4.06) is better than 84.80% of its industry peers.
CNR has a debt to FCF ratio of 0.52. This is a very positive value and a sign of high solvency as it would only need 0.52 years to pay back of all of its debts.
The Debt to FCF ratio of CNR (0.52) is better than 89.22% of its industry peers.
A Debt/Equity ratio of 0.06 indicates that CNR is not too dependend on debt financing.
The Debt to Equity ratio of CNR (0.06) is better than 81.37% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.52
Altman-Z 4.06
ROIC/WACC1.91
WACC8.98%
CNR Yearly LT Debt VS Equity VS FCFCNR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 1.38 indicates that CNR should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.38, CNR is in line with its industry, outperforming 58.82% of the companies in the same industry.
CNR has a Quick Ratio of 1.16. This is a normal value and indicates that CNR is financially healthy and should not expect problems in meeting its short term obligations.
CNR has a Quick ratio (1.16) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.38
Quick Ratio 1.16
CNR Yearly Current Assets VS Current LiabilitesCNR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

5

3. Growth

3.1 Past

The earnings per share for CNR have decreased strongly by -40.76% in the last year.
The Earnings Per Share has been growing by 27.39% on average over the past years. This is a very strong growth
EPS 1Y (TTM)-40.76%
EPS 3Y106.08%
EPS 5Y27.39%
EPS Q2Q%-39.21%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-7.41%

3.2 Future

CNR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.19% yearly.
The Revenue is expected to grow by 30.15% on average over the next years. This is a very strong growth
EPS Next Y15.33%
EPS Next 2Y23.19%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year38.48%
Revenue Next 2Y30.15%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
CNR Yearly Revenue VS EstimatesCNR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B
CNR Yearly EPS VS EstimatesCNR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 5 10 15

8

4. Valuation

4.1 Price/Earnings Ratio

CNR is valuated cheaply with a Price/Earnings ratio of 6.69.
Compared to the rest of the industry, the Price/Earnings ratio of CNR indicates a somewhat cheap valuation: CNR is cheaper than 79.90% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 29.63, CNR is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 5.80, the valuation of CNR can be described as very cheap.
85.78% of the companies in the same industry are more expensive than CNR, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.68. CNR is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 6.69
Fwd PE 5.8
CNR Price Earnings VS Forward Price EarningsCNR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CNR is valued a bit cheaper than the industry average as 61.76% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, CNR is valued a bit cheaper than the industry average as 64.71% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 10.94
EV/EBITDA 5.98
CNR Per share dataCNR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

CNR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of CNR may justify a higher PE ratio.
CNR's earnings are expected to grow with 23.19% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.44
PEG (5Y)0.24
EPS Next 2Y23.19%
EPS Next 3YN/A

2

5. Dividend

5.1 Amount

With a yearly dividend of 0.50%, CNR is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 6.75, CNR is paying slightly less dividend.
With a Dividend Yield of 0.50, CNR pays less dividend than the S&P500 average, which is at 2.29.
Industry RankSector Rank
Dividend Yield 0.5%

5.2 History

CNR has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr YearsN/A
Div Non Decr YearsN/A
CNR Yearly Dividends per shareCNR Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 0.5 1 1.5 2 2.5

5.3 Sustainability

2.04% of the earnings are spent on dividend by CNR. This is a low number and sustainable payout ratio.
DP2.04%
EPS Next 2Y23.19%
EPS Next 3YN/A
CNR Yearly Income VS Free CF VS DividendCNR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M
CNR Dividend Payout.CNR Dividend Payout, showing the Payout Ratio.CNR Dividend Payout.PayoutRetained Earnings

CORE NATURAL RESOURCES INC

NYSE:CNR (2/21/2025, 8:10:25 PM)

After market: 77.84 0 (0%)

77.84

-3.95 (-4.83%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)02-20 2025-02-20/bmo
Earnings (Next)05-05 2025-05-05/bmo
Inst Owners86.65%
Inst Owner Change-88.77%
Ins Owners2.03%
Ins Owner Change15.88%
Market Cap4.23B
Analysts80
Price TargetN/A
Short Float %6.36%
Short Ratio3.32
Dividend
Industry RankSector Rank
Dividend Yield 0.5%
Yearly Dividend2.34
Dividend Growth(5Y)N/A
DP2.04%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)41.96%
Min EPS beat(2)-0.26%
Max EPS beat(2)84.18%
EPS beat(4)3
Avg EPS beat(4)31.4%
Min EPS beat(4)-0.26%
Max EPS beat(4)84.18%
EPS beat(8)6
Avg EPS beat(8)21.93%
EPS beat(12)9
Avg EPS beat(12)29.3%
EPS beat(16)11
Avg EPS beat(16)11.18%
Revenue beat(2)2
Avg Revenue beat(2)8%
Min Revenue beat(2)1.71%
Max Revenue beat(2)14.28%
Revenue beat(4)4
Avg Revenue beat(4)6.2%
Min Revenue beat(4)1.71%
Max Revenue beat(4)14.28%
Revenue beat(8)7
Avg Revenue beat(8)7.1%
Revenue beat(12)11
Avg Revenue beat(12)12.45%
Revenue beat(16)13
Avg Revenue beat(16)10.01%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 6.69
Fwd PE 5.8
P/S 1.87
P/FCF 10.94
P/OCF 7.37
P/B 2.77
P/tB 2.77
EV/EBITDA 5.98
EPS(TTM)11.64
EY14.95%
EPS(NY)13.42
Fwd EY17.25%
FCF(TTM)7.12
FCFY9.14%
OCF(TTM)10.56
OCFY13.56%
SpS41.61
BVpS28.12
TBVpS28.12
PEG (NY)0.44
PEG (5Y)0.24
Profitability
Industry RankSector Rank
ROA 14.61%
ROE 26.98%
ROCE 20.61%
ROIC 17.15%
ROICexc 20.97%
ROICexgc 20.97%
OM 20.8%
PM (TTM) 18.23%
GM 35.16%
FCFM 17.1%
ROA(3y)14.37%
ROA(5y)9.11%
ROE(3y)31.32%
ROE(5y)21.93%
ROIC(3y)21.68%
ROIC(5y)14.45%
ROICexc(3y)24.62%
ROICexc(5y)16.26%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)26.04%
ROCE(5y)17.36%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y292.82%
ROICexc growth 5Y24.61%
OM growth 3Y181.05%
OM growth 5Y11.64%
PM growth 3YN/A
PM growth 5Y20.82%
GM growth 3Y-22.64%
GM growth 5Y-14.47%
F-Score6
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.52
Debt/EBITDA 0.13
Cap/Depr 83.74%
Cap/Sales 8.27%
Interest Coverage 250
Cash Conversion 82.71%
Profit Quality 93.78%
Current Ratio 1.38
Quick Ratio 1.16
Altman-Z 4.06
F-Score6
WACC8.98%
ROIC/WACC1.91
Cap/Depr(3y)68.08%
Cap/Depr(5y)65.4%
Cap/Sales(3y)8.1%
Cap/Sales(5y)8.95%
Profit Quality(3y)238.22%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-40.76%
EPS 3Y106.08%
EPS 5Y27.39%
EPS Q2Q%-39.21%
EPS Next Y15.33%
EPS Next 2Y23.19%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-7.41%
Revenue Next Year38.48%
Revenue Next 2Y30.15%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-43.67%
EBIT growth 3Y283.13%
EBIT growth 5Y23.62%
EBIT Next Year-28.13%
EBIT Next 3Y7.38%
EBIT Next 5Y-12.64%
FCF growth 1Y-0.31%
FCF growth 3Y151.66%
FCF growth 5Y20.84%
OCF growth 1Y3.99%
OCF growth 3Y87.91%
OCF growth 5Y15.72%